By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic gene developer DNA 2.0 said today that it will use a grant from the National Science Foundation to continue to advance its synthetic biology technologies, with a specific focus on mammalian cells.

The firm plans to use the Small Business Innovation Research award to extend its gene optimization algorithms for protein expression, which is used in producing hosts for human therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.